IGHE and Alzheimer disease: In particular, AD patients with IgE antibodies against S. aureus had an almost twofold increase in the relative risk (1.91; P = .0093) associated with severe AD compared to AD patients without IgE antibodies against S. aureus antigens (Figure 3, Table S2C).